| Michelle B Mohageg, DO | |
|
25825 Vermont Ave, Harbor City, CA 90710-3518 | |
| (310) 325-5111 | |
| Not Available |
| Full Name | Michelle B Mohageg |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 25825 Vermont Ave, Harbor City, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134288798 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20A6578 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Torrance Memorial Medical Center | Torrance, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthcare Partners Affiliates Medical Group | 7315842002 | 658 |
News Archive
Dec. 1 is World AIDS Day, and in commemoration of the occasion, the HIV Vaccine Trials Network, headquartered at Fred Hutchinson Cancer Research Center, debunks the top 10 myths about HIV vaccine research.
A UCLA-led consortium of five University of California medical schools, plus Cedars-Sinai Medical Center in Los Angeles, has received $9.9 million from the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality to research the use of wireless and telephone care management to reduce hospital readmissions for heart failure patients.
Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.
Researchers have uncovered a link between the structure of the protein alpha-synuclein and its likelihood to misfold and aggregate.
› Verified 8 days ago
| Entity Name | Healthcare Partners Affiliates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659312593 PECOS PAC ID: 7315842002 Enrollment ID: O20031204001258 |
News Archive
Dec. 1 is World AIDS Day, and in commemoration of the occasion, the HIV Vaccine Trials Network, headquartered at Fred Hutchinson Cancer Research Center, debunks the top 10 myths about HIV vaccine research.
A UCLA-led consortium of five University of California medical schools, plus Cedars-Sinai Medical Center in Los Angeles, has received $9.9 million from the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality to research the use of wireless and telephone care management to reduce hospital readmissions for heart failure patients.
Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.
Researchers have uncovered a link between the structure of the protein alpha-synuclein and its likelihood to misfold and aggregate.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle B Mohageg, DO 25825 Vermont Ave, Harbor City, CA 90710-3518 Ph: (310) 325-5111 | Michelle B Mohageg, DO 25825 Vermont Ave, Harbor City, CA 90710-3518 Ph: (310) 325-5111 |
News Archive
Dec. 1 is World AIDS Day, and in commemoration of the occasion, the HIV Vaccine Trials Network, headquartered at Fred Hutchinson Cancer Research Center, debunks the top 10 myths about HIV vaccine research.
A UCLA-led consortium of five University of California medical schools, plus Cedars-Sinai Medical Center in Los Angeles, has received $9.9 million from the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality to research the use of wireless and telephone care management to reduce hospital readmissions for heart failure patients.
Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.
Researchers have uncovered a link between the structure of the protein alpha-synuclein and its likelihood to misfold and aggregate.
› Verified 8 days ago
Lynnea Wilson Morm, Family Medicine Medicare: Medicare Enrolled Practice Location: 1403 Lomita Blvd Ste 102, Harbor City, CA 90710 Phone: 310-534-7600 | |
Dr. Charles Bui, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-517-4027 | |
Christine Nguyen Dao, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Department Of Family Medicine, Harbor City, CA 90710 Phone: 310-325-5111 | |
Natalie Ting, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Dr. Elvina L Torres-campos, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1403 Lomita Blvd Ste 102, Harbor City, CA 90710 Phone: 310-534-7600 | |
Lisa M. Young, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Vanessa Gavin-headen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 |